320 Bent Street
available to Lease
in Cambridge, MA
posted on May 31, 2012
Director of Economic Development
On behalf of BioMed Realty Trust, Richards Barry Joyce & Partners is pleased to present an exciting leasing opportunity at 320 Bent Street in Cambridge, Massachusetts. 320 Bent Street is a 195,198 square foot First Class Offi ce/R&D building in the heart of the East Cambridge Laboratory/Biotechnology Market. The building features a state-of-the-art design which will meet and surpass tenants’ most challenging infrastructure needs. 320 Bent Street is minutes from downtown Boston/Logan Airport, Harvard Square and Back Bay. Tenants enjoy excellent access via I-93 and close proximity to the Red Line (Kendall) and the Green Line (Lechmere) MBTA Stations and the EZ Ride Shuttle Bus. Tenants also enjoy a thriving neighborhood with shops, restaurants and cinemas at Kendall Square. Neighboring institutions and corporations include MIT, Genzyme, Amgen, Biogen, Whitehead Institute, Merck, Ironwood, Novartis and Broad Institute.
Biotech Infrastructure Amenities
Building Size: 195,198 square feet
Year Built: 2002
Number of Floors: Six (including Basement & Penthouse)
Floor Load Capacity: Floors 1-4: 100 lbs. per RSF Mechanical Penthouse: 250 lbs. per RSF
Floor to Floor Height: Floors 1-4: 16’
Mechanical Penthouse: 18’
Loading Dock: One shared central dock equipped with two vehicle access spaces
Electricity: 5,000 KVA total delivery to building via two switchboards (3,000 KVA & 2,000 KVA)
Capacity of approx. 10 watts/RSF
HVAC: 2 CFM per square foot, 100% outside air delivered from custom air handling units. Water cooled chillers with 15% additional capacity for supplemental cooling. Hot water boilers for heating.
Underground Parking: 1 space per 1,000 USF (at market rates)
|Property Use||Lab, Office|
|Parking||This property has parking available|
|Building Size (in Square Feet)||195,198|
|Square feet available||40,000|
|Date of Construction||2002|
|Property Owner||BioMed Realty Trust|
Images (Click on images to view larger size)
MassBio is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Founded in 1985, MassBio represents over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.
- July 8, 2014 Bentley's Ledley Testifies at 21st Century Cures Hearing
- July 8, 2014 MLSC launches the first round of Fiscal Year 2015 Accelerator Loan Program
- July 7, 2014 NextCODE, University College Dublin’s ACoRD Take Aim at Genetic Causes of Autism and Rare Diseases
- July 1, 2014 Member Briefing: FDA Social Media Guidances
- July 1, 2014 Moderna Appoints Oncology Leader Dr. Stephen Kelsey as President of Onkaido